NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/27/2024
Back to search
Official data from USPTO
XCELLIT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
02/27/2024
Classification
Registered
Trademark type
Combined
Nice classes
9, 10, 42, 44
Filing date
11/05/2022
Registration date
02/27/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/27/2024
Last transaction
02/27/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
5
Owner type
03
Owner location
Mechelen, BE
Examiner
BERLIN, JUSTIN
Law office
N70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the stylized word "XCELLIT".
Holders and representatives
Holders
Galapagos NV
Representatives
Alexandra MacKay STITES & HARBISON PLLC
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
recorded software used as medical monitoring and control toolspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; recorded software as a medical device (SaMD)specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; recorded computer software for use in medical decision support systems specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment
Class 10
Medical apparatus and instruments for use in apheresisproduction of cell and gene therapiestestinganalysisquality assurance of cell and gene therapiesinfusion of cell and gene therapiesanalysis of data gathered from the cell and gene therapy treatment; apparatus and instruments for cell analysis for medical usecancer and autoimmune disease treatment; medical apparatus in the nature of a system comprising an automated manufacturing devicereagentssoftware for the purpose of coordinating the treatment of patientsmonitoring and conducting quality control on the testing of blood derived cellssupporting clinical decisions regarding the use of such cells for infusion and treatmentthe analysis of the results from such treatment
Class 42
Software as a service (SAAS) services featuring software for medical monitoring and control specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowscheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; providing temporary use of nondownloadablecloud-based software featuring software for medical monitoring and control specificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment information; software as a service (SAAS) services for use in medical decision support systemsspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; providing temporary use of non-downloadablecloud-based software featuring software for use in medical decision support systemsspecificallysoftware that coordinates the treatment of patientsthat monitors and controls manufacturesupplyworkflowcoordinates scheduling of delivery of chimerin antigen receptor T-cell therapythat records patient statustreatmentvitalsthat gathersstoressendsmakes accessible patient data and treatment informationthat supports clinical decisions regarding the use of blood derived cells for infusion and treatment and the analysis of the results from such treatment; Providing information about the results of clinical trials for pharmaceutical products; scientific research in the nature of conducting clinical trials; Providing information about the results of clinical trials; evaluation pharmaceutical products in the nature of product quality testing; providing information regarding the product quality testing and clinical trials of pharmaceutical products; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and pharmaceutical product quality testing; advisory and consultancy services in the field of medical and pharmaceutical product development
Class 44
Medical services; medical and pharmaceutical evaluation of medical and pharmaceutical products to determine effectiveness and suitability for use in treatment of specific medical conditions; medical servicescell therapy services; Medical services relating to the removaltreatment and processing of human cells
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/27/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2023
PUBO
PUBLISHED FOR OPPOSITION
12/12/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/06/2023
DOCK
ASSIGNED TO EXAMINER
11/06/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/17/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/24/2023
GNRT
NON-FINAL ACTION E-MAILED
08/24/2023
CNRT
NON-FINAL ACTION WRITTEN
08/24/2023
DOCK
ASSIGNED TO EXAMINER
08/21/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
01/19/2023
ALIE
ASSIGNED TO LIE
01/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/23/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
11/19/2022
NWAP
NEW APPLICATION ENTERED
11/09/2022
Continuous trademark protection
Get notified about every new filing that threatens XCELLIT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.